Danish healthtech company Aisel Health is raising its ambitions in mental healthcare after securing €1.7 million in pre seed funding to develop an AI powered operating system designed specifically for psychiatric and psychological care. The investment comes as mental health services face mounting demand, long waiting lists and a growing administrative burden that leaves clinicians with less time for patients.
Tackling a growing capacity crisis
The round was led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX and Angel Invest, alongside existing investors Rockstart and EIFO. The company plans to use the funding to expand its clinical and engineering teams and accelerate its entry into the UK market.
Aisel describes its platform as a clinical operating system for private psychiatric clinics rather than simply another AI documentation product. Its goal is to connect patient intake, consultation preparation, clinical documentation and administrative workflows around a single patient record.
Moving beyond AI scribes
AI medical scribes have become increasingly common because they can reduce the time clinicians spend writing notes. Aisel argues, however, that faster documentation does not necessarily solve the deeper problem facing psychiatry.
Clinicians still have to reconstruct a patient’s history from referrals, previous consultations, documents and other information before they can make decisions. Generating more notes can even make that challenge harder if important information becomes buried in large volumes of documentation.
Aisel instead aims to surface the relevant clinical context before, during and after appointments. Its platform can generate patient summaries from previous sessions and documentation, allowing clinicians to review key information before a consultation. Information can also be traced back to its original source.
Building a continuous patient picture
The company’s approach is centred on creating a continuously developing understanding of each patient.
Aisel’s platform combines AI supported intake, structured clinical information, contextual listening and documentation. Patients can complete adaptive conversations before appointments, while the system organises their responses into structured information for clinicians.
Its current platform includes AI intake and surveys, an AI scribe, clinical documentation and document generation. The company says its intake system allows patients to provide information before their first visit, while its scribe is designed to reduce time spent creating consultation notes.
The system can also support more complex psychiatric documentation, including court reports, Mental Health Act work, medico legal documents and benefits reports. Aisel says statements in these documents can be linked back to their underlying sources, allowing clinicians to verify information before signing.
Bringing more people into assessments
Aisel is also expanding the information collected beyond the patient and clinician interaction.
For assessments involving children, for example, relevant information may need to come from parents, teachers and other people involved in the patient’s life. AI supported conversations can help gather these perspectives and bring them into the same clinical workflow.
The objective is to reduce the manual coordination involved in collecting information while giving clinicians a more complete picture before making an assessment.
From documentation to clinic operations
Aisel’s ambitions extend beyond clinical notes. The company wants its platform to coordinate administrative work that happens around patients, including follow ups, appointment management and other tasks that can otherwise fall between different members of a clinic team.
Its broader vision is therefore to create an operating layer that connects clinicians, administrative staff and patient information rather than functioning as an isolated AI tool.
The platform is built for regulated healthcare environments, with GDPR compliant infrastructure, UK and EU data residency, end to end encryption and audit controls. Aisel also states that patient data is not used to train AI models.
UK expansion on the horizon
The new funding will support Aisel’s expansion into the UK, where the company is building a commercial pipeline among private psychiatry and neurodevelopmental assessment clinics. It is also continuing to develop its clinical and engineering capabilities ahead of a planned seed round.
Aisel’s wider ambition is to make psychiatric care more scalable without compromising clinical judgment. By bringing preparation, documentation, patient context and administrative coordination into one system, the company believes AI can give clinicians more time to focus on the part of healthcare that cannot be automated: understanding and treating the patient.
